The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Adamsson
I
I
Department of Immunology, Microbiology, Pathology and Infectious Diseases, Huddinge University Hospital, Karolinska Institute, S-141 86 Huddinge, Sweden.
Edlund
C
C
Seensalu
R
R
Engstrand
L
L
D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000942:Antigens, Bacterial; D001426:Bacterial Proteins / Q000235:genetics; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005408:Flagellin / Q000235:genetics; D005838:Genotype; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D016480:Helicobacter pylori / Q000235:genetics* / Q000472:pathogenicity; D008795:Metronidazole / Q000008:administration & dosage; D009853:Omeprazole / Q000008:administration & dosage; D010406:Penicillins / Q000008:administration & dosage; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D012008:Recurrence; D017211:Treatment Failure; D014774:Virulence
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D010406:Penicillins; C074689:VacA protein, Helicobacter pylori; C080866:cagA protein, Helicobacter pylori; D005408:Flagellin; C067138:flaA protein, bacteria; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole